Related Experiment Video

Updated: Mar 13, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

6.7K

Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways

Ohad Oren1, B Douglas Smith2

  • 1Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, PA, USA.

Stem Cell Reviews and Reports
|October 13, 2016
PubMed

Insights

Cancer stem cells (CSCs) may drive tumor resistance and recurrence. Targeting embryonic signaling pathways in CSCs offers a promising strategy to improve patient survival in cancer therapy.

Area of Science:

  • Oncology
  • Developmental Biology

Background:

  • Recent advances in cancer biology and targeted therapies have improved treatment, but most tumors remain resistant and recur.
  • Cancer Stem Cells (CSCs), expressing pluripotency markers, share traits with normal stem cells and are implicated in tumor resistance and relapse.

Purpose of the Study:

  • To review key embryonic signaling pathways and their differential expression in CSCs.
  • To discuss these pathways as potential therapeutic targets for eliminating CSCs and improving patient outcomes.

Main Methods:

  • Review of scientific literature on embryonic signaling pathways.
  • Analysis of differential gene expression in CSCs related to these pathways.

Main Results:

  • CSCs rely on primitive regulatory pathways, often mirroring embryonic signaling.
  • Specific embryonic pathways are differentially expressed in CSCs, highlighting their regulatory role.

Conclusions:

  • Targeting embryonic signaling pathways in CSCs is a viable therapeutic strategy.
  • Eliminating CSCs through these novel approaches may enhance overall patient survival.
Keywords:
Cancer stem cellsEmbryonic signalingHIFHedgehog pathwayLymphomaNotch pathwayWnt pathway

More Related Videos

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

4.8K
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.8K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.2K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.9K